We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+16.3%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$36.7B
AUM Growth
+$4.73B
Cap. Flow
+$3.45B
Cap. Flow %
9.42%
Top 10 Hldgs %
15.54%
Holding
3,403
New
385
Increased
1,787
Reduced
944
Closed
189

Sector Composition

Rank Sector Weight
1 Healthcare 9.66%
2 Technology 9.09%
3 Financials 7.96%
4 Consumer Staples 7.25%
5 Industrials 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGH
3026
DELISTED
Pengrowth Energy Corporation
PGH
$74K ﹤0.01%
46,876
-300
-0.6% -$470
REFR icon
3027
Research Frontiers
REFR
$17M
$73K ﹤0.01%
28,000
FOMX
3028
CALL
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$73K ﹤0.01%
+36,700
New +$307K
DELL icon
3029
CALL
Dell
DELL
$293B
$72K ﹤0.01%
+159,989
New +$2.17M
WBA
3030
CALL
DELISTED
Walgreens Boots Alliance
WBA
$70K ﹤0.01%
94,800
+52,800
+126% +$4.31M
ARRY
3031
DELISTED
Array Biopharma Inc
ARRY
$70K ﹤0.01%
+10,400
New +$40.2K
CIE
3032
DELISTED
Cobalt International Energy, Inc
CIE
$70K ﹤0.01%
3,783
+18
+0.5% +$334
KSS icon
3033
CALL
Kohl's
KSS
$2.19B
$68K ﹤0.01%
+34,200
New +$1.43M
PMTS icon
3034
CPI Card Group
PMTS
$320M
$68K ﹤0.01%
2,240
-1,590
-42% -$41.1K
GSAT icon
3035
Globalstar
GSAT
$10.8B
$67K ﹤0.01%
3,700
+67
+2% +$1.26K
PAYX icon
3036
CALL
Paychex
PAYX
$42.7B
$67K ﹤0.01%
+87,700
New +$5.26M
XBI icon
3037
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$67K ﹤0.01%
27,500
+5,200
+23% +$322K
FUEL
3038
DELISTED
Rocket Fuel Inc.
FUEL
$67K ﹤0.01%
25,250
+4,650
+23% +$12.4K
CFR icon
3039
CALL
Cullen/Frost Bankers
CFR
$10.2B
$66K ﹤0.01%
21,300
-100
-0.5% -$6.92K
CME icon
3040
CALL
CME Group
CME
$94.8B
$66K ﹤0.01%
45,300
+400
+0.9% +$41.8K
NTBL
3041
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$66K ﹤0.01%
+362
New +$54.3K
NVAX icon
3042
Novavax
NVAX
$1.31B
$65K ﹤0.01%
1,554
-2,269
-59% -$293K
HL icon
3043
Hecla Mining
HL
$11.3B
$64K ﹤0.01%
11,243
-9,537
-46% -$58.3K
ASNA
3044
DELISTED
Ascena Retail Group, Inc.
ASNA
$64K ﹤0.01%
568
-1,128
-67% -$171K
ARCO icon
3045
Arcos Dorados Holdings
ARCO
$1.74B
$63K ﹤0.01%
12,334
HD icon
3046
CALL
Home Depot
HD
$355B
$63K ﹤0.01%
36,500
+18,100
+98% +$2.41M
JPM icon
3047
CALL
JPMorgan Chase
JPM
$950B
$63K ﹤0.01%
119,400
+29,700
+33% +$1.94M
SPY icon
3048
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$63K ﹤0.01%
45,000
+17,700
+65% +$3.83M
HOG icon
3049
CALL
Harley-Davidson
HOG
$2.71B
$62K ﹤0.01%
42,900
-13,500
-24% -$698K
SRL icon
3050
Scully Royalty
SRL
$87.1M
$62K ﹤0.01%
6,070

Similar funds

Raymond James & Associates's Q3 2016 Portfolio in Review

As of Q3 2016, Raymond James & Associates held 3,403 positions worth $36.7B, up 15% from $31.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James & Associates deployed $3.45B of net new capital in Q3 2016, opening 385 new positions and adding to 1,787 existing holdings. Its largest new stake was iShares MSCI India Small-Cap ETF: 414,364 shares worth $15.2M.

By sector, the portfolio is most concentrated in Healthcare at 9.7% of assets, up from 9.6% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was TotalEnergies, an estimated $614M trimmed.

  • Raymond James & Associates's largest Q3 2016 buy was iShares MSCI India Small-Cap ETF: 414,364 shares worth $15.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2016, an estimated $196M increase.
  • Raymond James & Associates's biggest Q3 2016 reduction was TotalEnergies, cutting an estimated $614M.
  • Raymond James & Associates fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $61.1M.
  • Raymond James & Associates's ten largest holdings make up 16% of its $36.7B portfolio in Q3 2016.
  • Raymond James & Associates opened 385 new positions and closed 189 in Q3 2016.
  • Raymond James & Associates's portfolio value rose 15% quarter-over-quarter to $36.7B.

Based on Raymond James & Associates's 13F filing for Q3 2016, filed 14 Nov 2016.